This study investigated the ability of anaerobic periodontal bacteria to inactivate and resist killing by antimicrobial peptides through production of extracellular proteases. Antibacterial activities of peptides were assessed in a double-layer agarose diffusion assay, and MlCs and MBCs were determined in broth microdilution assays. Culture supernates of Porphyromonas gingivalis and Prevotella spp. inactivated mastoparan, magainin II and cecropin B whilst Gram-positive oral supragingival bacteria had no effect. Inactivation was prevented by protease inhibitors and was unaffected by 45% human serum. Purified proteases from the periodontopathogen Porph. gingivalis inactivated peptides [cecropin B, brevinin, CAMEL (cecropin A 1-7 + melittin 2-9), mastoparan] as would be predicted from the amino acid sequences of the peptides and the known bond specificities of these Arg-x and Lys-x enzymes. MALDI-TOF M S revealed that inactivation of cecropin B by Porph. gingivalis protease was due to specific cleavage of the molecule. Inactivation of cecropin B by proteases took 10-15 min. Paradoxically, MlCs of cecropin B against Porph. gingivalis and Prevotella intermedia were low, while Prevotella nigrescens was resistant, suggesting that production of proteases alone is insufficient to protect Porph. gingivalis and Prev. intermedia from the action of antimicrobial peptides. Thus, antimicrobial peptides could be developed as therapeutic agents targeted against specific periodontal pathogens.
INTRODUCTION
Low-molecular-mass polycationic antimicrobial peptides, with activity against a range of Gram-positive and Gram-negative bacteria, fungi and viruses (Hancock et al., 1995) , are emerging as significant host defence and immune effector molecules which are involved in intracellular killing and mucosal defence (Lehrer et al., 1993 ; Bevins, 1994; Bensch et al., 1995 ; Schonwetter et al., 1995 ; Zhao et al., 1996) . The antimicrobial activity of cationic peptides in combination with their other functions in host defence and recovery (Martin et al., 1995) has led to investigations of their potential as therapeutic agents for use against microbial infections and against cancer.
Antimicrobial peptides are present in the human mouth. Neutrophil granules contain defensins and the human cathelicidin LL-37 (Ganz & Weiss, 1997) , while salivary glands produce histatins (Oppenheim et al., 1988) and pdefensins 1 and 2 (W. Bonass, A. S. High, I?. J. Owen & D. A. Devine, unpublished results) , and P-defensin 1 is produced by gingival epithelial cells (Krisanaprakornkit et al., 1998) . Thus, interactions between bacteria and host antimicrobial peptides may be important in selecting the diverse commensal microbiota colonizing oral mucosae, and in regulating the pathogenic potential of some organisms. Many of these organisms, some of which are important opportunistic pathogens, are highly proteolytic (Grenier & Turgeon, 1994) and this activity is known to contribute to nutrient acquisition, tissue destruction a n d de-regulation of inflammatory responses (Travis et al., 1995) . It is also possible that production of proteases enables oral bacteria to evade killing by antimicrobial peptides, thus contributing to the virulence of such opportunistic pathogens. This would also have implications for the use of antimicrobial peptides as therapeutic agents t o treat oral diseases.
Consequently, this study investigated the ability of the proteolytic anaerobes Porphyromonas girtgivalis a n d Prevotella spp. t o modulate the activity of a range of known antimicrobial peptides.
Bacterial strains and growth conditions. Eleven of 18 strains employed in the study (see Table 3 ) were from culture collections. The non-oral strain HSTll56-3, provided by P. Brahani (Research Centre in Oral Biology, University of Washington, USA), was originally identified as an atypical Prevotella intermedia but was subsequently shown to belong to a previously undescribed species Pearce et al., 1996) . Actinomyces naeslundii strains were provided by P. S. Handley (Dept of Cell & Structural Biology, University of Manchester, UK) and Escherichia coli BUE55 by R. Dixon (Dept of Biomedical Sciences, University of Bradford, UK) .
Gram-negative anaerobes were grown on pre-reduced Columbia agar (Oxoid CM331) plus 5 ' / o (v/v) horse blood, or in Brain Heart Infusion broth (BHI; Oxoid CM225) plus haemin (1 mg 1-l) and menadione (0.5 mg 1-'), at 37 "C in an Anaerobic Work Station (Don Whitley Scientific) under an atmosphere of 80 o/ o nitrogen, 10 '/ o hydrogen and 10 ' / o carbon dioxide. The Gram-positive isolates were grown in BHI containing 0.3% (w/v) yeast extract in a high CO, environment formed using gas-generating envelopes (Oxoid BR39), except Streptococcus mutans NCTC 10449, which was grown anaerobically. E. coli BUE55 was used to assess peptide activity; this strain was originally isolated because of its increased sensitivity to polymyxin B and has been used in other studies of antimicrobial peptides (Moore, 1993 ; Moore et al., 1996) . It was grown aerobically at 37 "C on Columbia agar base (Oxoid CM331) or in Isosensitest broth (ISB; Oxoid, CM473). All bacteria were stored at -80 "C in sterile glycerol (30 '/o, v/v).
Peptides. Sequences of the peptides used are shown in Table 1 . Cecropin B, magainin I1 and mastoparan were purchased from Sigma. Brevinin, CAMEL (cecropin A 1-7 + melittin 2-9) and the SLS fragment of bovine seminal plasmin were synthesized by Proteus Molecular Design on a Novasyn Crystal automated synthesizer by standard FMOC (fluorenylmethoxycarbonyl) phase methodology and their purity ( > 97 9'0) was assessed by HPLC. Seminal plasmin fragment was dissolved in 0.01 ' / o (v/v) acetic acid, and the other peptides were dissolved in 0.1 M phosphate buffer, pH 6.4. Lyophilized powders and solutions of peptides were stored at -20 "C and -80 "C, respectively.
Determination of peptide activity. The biological activity of peptides was assessed by determining their ability to kill E. coli BUE55 in a double-layer diffusion assay based on that of Lehrer et al. (1991) . This assay was selected for most experiments because it uses very small amounts of peptide. The test organism was grown in ISB to exponential phase, and the suspension was adjusted with sterile ISB to an OD,,, corresponding to approximately 2 x lo6 c.f.u. ml-'. Plates were poured containing 12 ml half-strength ISB plus 1 ' / o (w/v) low electroendosmotic agarose (Sigma) and 0.02 ' / o (v/v) Tween 20 (Sigma), following inoculation of the molten (50°C) medium with 1OOpl adjusted suspension of E. coli BUE55. Peptide preparations (2 pl) were added to 1.5-mmdiameter wells which had been cut using sterile Pasteur pipettes, and plates were incubated aerobically at 37 "C for 3 h. Finally the plates were overlaid with 12 ml molten (50 "C) double-strength ISB containing 1 ' / o (w/v) agarose (Sigma), and were incubated overnight aerobically at 37 "C. Negative controls comprised wells containing 0.1 M phosphate buffer, p H 6.4, or 0.01
The MICs of peptides against anaerobic bacteria were determined in a broth microdilution assay. All steps were carried out under continuous anaerobic conditions in an Anaerobic Work Station (Don Whitley Scientific). Doubling dilutions of peptides were made in pre-reduced BHI plus haemin and menadione and 15 pl of each dilution was placed in wells of a 96-well microtitre tray containing 130 p1 prereduced BHI plus haemin and menadione. Wells were inoculated with bacterial suspension (final concentration approx. 5 x 10' c.f.u. ml-') and, after incubation anaerobically at 37 "C for 24 h, MICs were recorded as the lowest concentration of peptide inhibiting growth of the bacteria. Positive controls included wells inoculated with E. coli BUESS, and negative controls contained either no peptide or no bacteria. MBCs of peptides were determined after overnight incubation, by inoculating samples from wells onto prereduced Columbia agar plus 5 % (v/v) horse blood. Preliminary experiments compared MICs obtained using polypropylene microtitre trays (Corning Laboratory Sciences) with those obtained using polystyrene trays (Sigma) and results differed by no more than one dilution. Cecropin B is highly bound to bacteriological and cell culture media (Moore, 1993; Moore et al., 1994) . The methodology employed here of diluting small volumes of peptide solution in large volumes of broth may have resulted in binding of the peptide to medium components before it could bind to the surfaces of the microtitre trays.
Porph. gingiwalis proteases. Arg-x-specific proteases (RIA and RIB) and Lys-x-specific protease (Kgp) were purified from culture supernate and whole cells, respectively, of stationary phase cultures of Porph. gingivalis W50. Purification of Arg-x proteases has been described in detail previously (Rangarajan et al., 1997) . For purification of Lys-x enzyme, 2 1 1-d-old cultures of Porph. gingivalis W50 was harvested by centrifugation at 10000 g for 1 h at 4 "C. The cell pellet was washed in 50 mM MOPS buffer, pH 6*0/10 m M 2-mercaptoethanol and Centrifuged as above. The washed cells were resuspended in 50 ml buffer and sonicated in a Soniprep 150 at 12 p amplitude for 6 x 1 min bursts, on ice, with thorough cooling in between. The cell extract was centrifuged at 18000g for 30 min at 4 "C. The supernatant was applied to a column of Arg-agarose (2.6 cm i.d. Suspensions of organisms grown to stationary phase were adjusted to an OD,,, of 1.0 and centrifuged for 4 min at 11 600 g in a microcentrifuge (Sanyo MSE Microcentaur).
Equal volumes of culture supernates and peptide solution were mixed and incubated at 37 "C for 1 h under gaseous conditions appropriate to the growth of the organism whose culture supernate was being tested. The peptide/supernate mixtures and the supernates or peptides alone were then tested for antimicrobial activity by the double-layer diffusion method in at least three independent experiments. To examine inactivation of peptides by purified Porph. gingivalis proteJses, peptides were diluted in 10 m M L-cysteine/lO m M CaCl.,/'lOO m M Tris/HCl, p H 8-0, and mixtures containing protease and peptide were incubated anaerobically at 37 "C for 1 h. In some experiments, the protease inhibitor Na-ptosyl-L-lysine chloromethyl ketone (TLCK) was added to supernate/peptide or enzyme/peptide mixtures to a final concentration of 100 pM, or a mixture of inhibitors was added comprising: PMSF (1 mM), leupeptin (100 pM), benzamidine (5 mM) and EDTA (10 mM). In others, sterile normal human serum (Sigma S7023) was added to final concentrations ranging from 5 to 45% (v/v). MALDI-TOF MS to detect peptide breakdown products was performed using a Voyager STR Biospectrometry Research Station laser-desorption mass spectrometer coupled with Delayed Extraction, at M-Scan. The samples were dissolved in 1000 pl 0.1 '/o (v/v) aqueous trifluoroacetic acid and aliquots (0.5 p1) of the solution were analysed using a matrix of orcyano-4-hydroxycinnamic acid. A matrix blank was also analysed. Angiotensin I was used as an external calibrant.
RESULTS

Peptide activity in double-layer diffusion assays
Cecropin B and CAMEL were the m o s t potent of the natural peptides tested against E. coli BUE5.5 in the double-layer diffusion assay (Table 2) . M i n i m u m concentrations of t h e remaining peptides inhibiting g r o w t h of BUE5.5 ranged from 25 t o 300 pM. Preliminary experiments a n d previous studies (Moore, 1993 ; M o o r e et al., 1996) indicated t h a t ISB gave larger and clearer zones of inhibition w h e n compared with other media (Mueller-Hinton agar, Diagnostic Sensitivity T e s t agar,
Brain H e a r t Infusion a g a r ; Oxoid). In the assay 
employed here, antimicrobial activity could be detected easily for all of these peptides, allowing determination of the effects of culture supernates and isolated enzymes on their antimicrobial function.
Inhibition of peptide activity by bacterial culture su perna tes
After they had been incubated with culture supernates of each of the Gram-negative anaerobic bacteria, cecropin B (25 pM) and magainin I1 (50 pM) showed no inhibition of growth of E. coli BUE55 in the double-layer diffusion assay, indicating total inactivation of the peptides (Table  3 ) . Mastoparan (125 pM) was fully inactivated by culture supernates of all Prevotella spp., and after incubation with supernates from Porph. gingivalis W50
and HST 1156-3 only a small amount of activity (indicated by small zones of inhibition) remained. Conversely, culture supernates of Gram-positive species had no effect, with the exceptions of Rothia dentocariosa NCTC 10918 (which inactivated 5 pM cecropin B) and Actinomyces odontolyticus NCTC 9335 (which inactivated 5 pM cecropin B and 50 pM magainin IT).
Culture supernates from all other Gram-positive isolates had no effect on as little as 5 pM cecropin B. The short SLS fragment of seminal plasmin was resistant to inactivation by any bacterial culture supernate tested.
Normal human serum (45 Yo, v/v) had no effect on the ability of culture supernates of Porph. gingivalis to inactivate cecropin B. Cecropin B itself was active in the presence of 5 -4 5 ' / o human serum but exhibited reduced zones of inhibition. When a mixture of protease inhibitors was incubated with culture supernates and cecropin B before testing peptide activity in agar diffusion assays, peptide inactivation did not occur. This indicates that the components in the culture supernates responsible for peptide inactivation were proteases. The inclusion of 100 pM TLCK alone had the same effect as the inhibitor mixture with culture supernates of Porph. gingivalis W50 and NCTC 11834.
Inhibition of peptide activity by purified proteases
Proteases of Porph. gingivalis are well characterized, and the interactions between peptides and purified proteases from Porph. gingivalis were studied further (Table 4) . Cecropin B, containing Arg and Lys residues, was inactivated by Arg-x and Lys-x proteases of Porph. gingivalis. When enzyme preparations standardized to 2 U ml-' were mixed with 25 pM cecropin B, the initial inactivation was rapid ; cecropin B activity was inhibited within 2.5 min to the extent that zones of inhibition of E. coli BUE55 were reduced by RIA to 59% (k 18) of the control and to 46% (k 14) by LYSII. The peptide was completely inactivated by RIA and RIB within 15 min and by Kgp within 10 min.
The SLS fragment of bovine seminal plasmin also contains Arg and Lys residues; it was, however, unaffected by any of the Porph. gingivalis proteases.
Brevinin, CAMEL and mastoparan differ in structural Brevinin FLPVLAGIAAKVVPALFCKITKKC (one S-S bridge) 100
KWKLFKKIGAVLKVL 500 Mastoparan INLKALAALAKKIL (amidated C-terminus) 500
--+Arginine and lysine residues (R and K), which are susceptible to cleavage by Porph. gingivalis proteases, are highlighted in bold.
characteristics and length but all contain Lys and no Arg residues. All were fully inactivated by the Lys-x-specific protease Kgp. The Arg-x-specific proteases did not inactivate these peptides, although brevinin was slightly inhibited by RIA.
RIA and RIB activities against cecropin B were unaffected by 40% normal human serum, but the enzymes were unable to cleave cecropin B in the presence of 45 % serum. The ability of Kgp to inactivate cecropin B was unaffected by 45% human serum.
Detection of peptide breakdown products
MALDI-TOF MS indicated that RIA cleaved specifically at the C-terminal side of L-Arg residues in cecropin B, as indicated in bold in the following sequence:
IAVLG""EAKAL35C0.NH2. Cecropin B gave a major signal with a peak top mass at m/z 3834.2. A signal for the doubly charged component was observed with a peak top mass at m/z 1917.17. There was also a signal at m/z 3294-04 which represents cecropin peptide residues F5 -+ L3.5. RIA gave signals consistent with those of the matrix ~-cyano-4-hydroxycinnamic acid. In the case of cecropin B treated with RIA, the molecular ion at m / z 3834.2 and peptide ion (residues 5 --+ 35) at m / z 3294.04 disappeared, suggesting that digestion to lower-molecular-mass peptides had occurred. Signals for peptides at residues 5 -+ 13, residues 14 -+ 16 and residues 17 -+ 35 were observed consistent with cleavage at Arg13 and Arg". No cleavage occurred at Lys residues, of which there are seven, in cecropin B.
Determination of MlCs of cecropin B against Porph. gingivalis and Prevotella spp.
Having determined that Porph. gingivalis and Prevotella spp. could efficiently inactivate antimicrobial peptides through production of proteases in culture supernates, the MICs of the most potent peptide, cecropin B, against these organisms were determined. Porph. gingivalis W50 Serratia marcescens (Flyg & Xanthopoulos, 1983) . Porph. gingivalis and Prev. intermedia were also killed by protegrin (Miyasaki et al., 1998) , a porcine neutrophil antimicrobial peptide, although the D-enantiomer of protegrin was slightly more effective, indicating that protease activity may contribute a small amount (of protection. The lack of more significant protection by proteases may be partly explained by the finding that full inactivation of cecropin B by Porph. gingivalis proteases took place quite slowly (10-15 min), whereas action on membranes occurs very rapidly. Additionally, sensitivity to peptides is complex and is determined by a number of properties, including (i) charge density and structure of lipopolysaccharide, as well as lipid composition of the cytoplasmic membrane and the presence of an electrochemical potential across the membrane (Hancock et al., 1995) ; (ii) responses of bacterial cells to environmental changes and stresses (Groisman et al., 1992; Para-Lopez et al., 1993 ,1994 ; and (iii) peptide transport mechanisms (Groisman et al., 1992; Para-Lopez et al., 1993 , 1994 .
Although the role of proteases from Porph. gingivalis and Prevotella spp. in prevention of direct killing or inhibition by antimicrobial peptides may not be significant, their actions may still contribute to the disease process through interfering with the multiple functions in host defence and recovery exhibited by antimicrobial peptides. These include chemoattraction of inflainmatory cells, cell proliferation, wound healing, binding to components of cascades regulating inflammatory processes and endotoxin neutralization (Martin et d., 1995; Chertov et al., 1996) . The extensive production of extracellular vesicles by Porph. gingivalis, Prev. intermedia and Prev. nigrescens (Grenier & Mayrand, 1987; Devine et al., 1989) would allow proteases to act at sii:es distant to their own surfaces, potentially providing protection to other species in subgingival plaque through disruption of a range of host defence functions.
It has been suggested that the vast array of antimicrobial peptides found in diverse animal, plant and insect species have evolved in response to the commensal and pathogenic organisms specific to that species and site of production (Boman, 1996; Zhao et al., 1996) . It is possible to speculate that the ability to resist the action of antimicrobial peptides is a significant factor determining the ability of commensal periodontal bacteria to colonize mucosal epithelia, and that this may be a key property of members of the resident microbiota. Further studies with active human antimicrobial peptides are required to determine the significance of the relative resistance observed here of the non-pathogenic commensal Prev. nigrescens (Tanner, 1991; Gmur & Guggenheim, 1994) , compared with the sensitivity of the periodontopathogenic Porph. gingivalis and Prev. intermedia.
Antimicrobial peptides are potentially important as novel therapeutic agents against microbial infections and against cancer (Jacob & Zasloff, 1994; Moore et al., 1994; Paquette et al., 1997) , and probably show most immediate promise for development as topical agents. This makes them promising for oral diseases, as topical application of antimicrobial agents is easy and appropriate, and their use would not contribute to resistance to antibiotics normally used in treatment of more life-threatening bacterial infections. The finding that Porph. gingivalis and Prev. intermedia are much more sensitive to cecropin B than commensal species raises the possibility that antimicrobial peptides could be developed for therapy targeted against periodontal pathogens.
